Chargement en cours...
Pancreatic biomarkers: Could they be the answer?
Pancreatic ductal adenocarcinoma (PDA) is known for its poor prognosis. Most of the patients are diagnosed with advanced stages, when no curative treatment is available. Currently, despite extensive clinical research on PDA, the median overall survival remains short. Diagnosis delay and primary chem...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Baishideng Publishing Group Inc
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4069311/ https://ncbi.nlm.nih.gov/pubmed/24976720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i24.7819 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|